The G8 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The G8 countries contributed $198,022.1 million in 2020 to the global generics industry, with a compound annual growth rate (CAGR) of 3.7% between 2016 and 2020. The G8 countries are expected to reach a value of $229,134.5 million in 2025, with a CAGR of 3% over the 2020-25 period.
- Among the G8 nations, the US is the leading country in the generics industry, with market revenues of $110,220.5 million in 2020. This was followed by Japan and Germany, with a value of $28,640.0 and $25,180.5 million, respectively.
- The US is expected to lead the generics industry in the G8 nations with a value of $124,141.2 million in 2016, followed by Japan and Germany with expected values of $32,238.2 and $28,441.8 million, respectively.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 generics market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 generics market
- Leading company profiles reveal details of key generics market players’ G8 operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the G8 generics market with five year forecasts by both value and volume
- Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country
Reasons to Buy
- What was the size of the G8 generics market by value in 2020?
- What will be the size of the G8 generics market in 2025?
- What factors are affecting the strength of competition in the G8 generics market?
- How has the market performed over the last five years?
- How large is the G8 generics market in relation to its regional counterparts?
Table of Contents
1 Introduction1.1. What is this report about?1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 Group of Eight (G8) Generics2.1. Industry Outlook
3 Generics in Canada3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
3.6. Macroeconomic Indicators
4 Generics in France4.1. Market Overview
4.2. Market Data
4.3. Market Segmentation
4.4. Market outlook
4.5. Five forces analysis
4.6. Macroeconomic Indicators
5 Generics in Germany5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
5.6. Macroeconomic Indicators
6 Generics in Italy6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
6.6. Macroeconomic Indicators
7 Generics in Japan7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
7.6. Macroeconomic Indicators
8 Generics in Russia8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis
8.6. Macroeconomic Indicators
9 Generics in The United Kingdom9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
9.6. Macroeconomic Indicators
10 Generics in The United States10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis
10.6. Macroeconomic Indicators
11 Company Profiles11.1. Teva Pharmaceutical Industries Limited
11.2. Apotex, Inc.
11.3. Les Laboratoires Servier
11.4. STADA Arzneimittel AG
11.5. Daiichi Sankyo Co Ltd
11.6. Sawai Pharmaceutical Co Ltd
11.7. Viatris Inc.
11.8. Krka, d. d., Novo mesto
11.9. Sanofi SA
11.10. Abbott Laboratories
11.11. Pfizer Inc.
12 Appendix12.1. Methodology
12.2. About the publisher
List of TablesTable 1: G8 generics industry, revenue($m), 2016-25
Table 2: G8 generics industry, revenue by country ($m), 2016-20
Table 3: G8 generics industry forecast, revenue by country ($m), 2020-25
Table 4: Canada generics market value: $ million, 2016-20
Table 5: Canada generics market volume: %, 2016-20
Table 6: Canada generics market geography segmentation: $ million, 2020
Table 7: Canada generics market value forecast: $ million, 2020-25
Table 8: Canada generics market volume forecast: %, 2020-25
Table 9: Canada size of population (million), 2016-20
Table 10: Canada GDP (constant 2005 prices, $ billion), 2016-20
Table 11: Canada GDP (current prices, $ billion), 2016-20
Table 12: Canada inflation, 2016-20
Table 13: Canada consumer price index (absolute), 2016-20
Table 14: Canada exchange rate, 2016-20
Table 15: France generics market value: $ million, 2016-20
Table 16: France generics market volume: %, 2016-20
Table 17: France generics market geography segmentation: $ million, 2020
Table 18: France generics market value forecast: $ million, 2020-25
Table 19: France generics market volume forecast: %, 2020-25
Table 20: France size of population (million), 2016-20
Table 21: France GDP (constant 2005 prices, $ billion), 2016-20
Table 22: France GDP (current prices, $ billion), 2016-20
Table 23: France inflation, 2016-20
Table 24: France consumer price index (absolute), 2016-20
Table 25: France exchange rate, 2016-20
Table 26: Germany generics market value: $ billion, 2016-20
Table 27: Germany generics market volume: %, 2016-20
Table 28: Germany generics market geography segmentation: $ billion, 2020
Table 29: Germany generics market value forecast: $ billion, 2020-25
Table 30: Germany generics market volume forecast: %, 2020-25
Table 31: Germany size of population (million), 2016-20
Table 32: Germany GDP (constant 2005 prices, $ billion), 2016-20
Table 33: Germany GDP (current prices, $ billion), 2016-20
Table 34: Germany inflation, 2016-20
Table 35: Germany consumer price index (absolute), 2016-20
Table 36: Germany exchange rate, 2016-20
Table 37: Italy generics market value: $ million, 2016-20
Table 38: Italy generics market volume: %, 2016-20
Table 39: Italy generics market geography segmentation: $ million, 2020
Table 40: Italy generics market value forecast: $ million, 2020-25
Table 41: Italy generics market volume forecast: %, 2020-25
Table 42: Italy size of population (million), 2016-20
Table 43: Italy GDP (constant 2005 prices, $ billion), 2016-20
Table 44: Italy GDP (current prices, $ billion), 2016-20
Table 45: Italy inflation, 2016-20
Table 46: Italy consumer price index (absolute), 2016-20
Table 47: Italy exchange rate, 2016-20
Table 48: Japan generics market value: $ billion, 2016-20
Table 49: Japan generics market volume: %, 2016-20
Table 50: Japan generics market geography segmentation: $ billion, 2020
Table 51: Japan generics market value forecast: $ billion, 2020-25
Table 52: Japan generics market volume forecast: %, 2020-25
Table 53: Japan size of population (million), 2016-20
Table 54: Japan GDP (constant 2005 prices, $ billion), 2016-20
Table 55: Japan GDP (current prices, $ billion), 2016-20
Table 56: Japan inflation, 2016-20
Table 57: Japan consumer price index (absolute), 2016-20
Table 58: Japan exchange rate, 2016-20
Table 59: Russia generics market value: $ billion, 2016-20
Table 60: Russia generics market volume: %, 2016-20
Table 61: Russia generics market geography segmentation: $ billion, 2020
Table 62: Russia generics market value forecast: $ billion, 2020-25
Table 63: Russia generics market volume forecast: %, 2020-25
Table 64: Russia size of population (million), 2016-20
Table 65: Russia GDP (constant 2005 prices, $ billion), 2016-20
List of FiguresFigure 1: G8 generics industry, revenue($m), 2016-25
Figure 2: G8 Generics industry, revenue by country (%), 2020
Figure 3: G8 generics industry, revenue by country ($m), 2016-20
Figure 4: G8 generics industry forecast, revenue by country ($m), 2020-25
Figure 5: Canada generics market value: $ million, 2016-20
Figure 6: Canada generics market volume: %, 2016-20
Figure 7: Canada generics market geography segmentation: % share, by value, 2020
Figure 8: Canada generics market value forecast: $ million, 2020-25
Figure 9: Canada generics market volume forecast: %, 2020-25
Figure 10: Forces driving competition in the generics market in Canada, 2020
Figure 11: Drivers of buyer power in the generics market in Canada, 2020
Figure 12: Drivers of supplier power in the generics market in Canada, 2020
Figure 13: Factors influencing the likelihood of new entrants in the generics market in Canada, 2020
Figure 14: Factors influencing the threat of substitutes in the generics market in Canada, 2020
Figure 15: Drivers of degree of rivalry in the generics market in Canada, 2020
Figure 16: France generics market value: $ million, 2016-20
Figure 17: France generics market volume: %, 2016-20
Figure 18: France generics market geography segmentation: % share, by value, 2020
Figure 19: France generics market value forecast: $ million, 2020-25
Figure 20: France generics market volume forecast: %, 2020-25
Figure 21: Forces driving competition in the generics market in France, 2020
Figure 22: Drivers of buyer power in the generics market in France, 2020
Figure 23: Drivers of supplier power in the generics market in France, 2020
Figure 24: Factors influencing the likelihood of new entrants in the generics market in France, 2020
Figure 25: Factors influencing the threat of substitutes in the generics market in France, 2020
Figure 26: Drivers of degree of rivalry in the generics market in France, 2020
Figure 27: Germany generics market value: $ billion, 2016-20
Figure 28: Germany generics market volume: %, 2016-20
Figure 29: Germany generics market geography segmentation: % share, by value, 2020
Figure 30: Germany generics market value forecast: $ billion, 2020-25
Figure 31: Germany generics market volume forecast: %, 2020-25
Figure 32: Forces driving competition in the generics market in Germany, 2020
Figure 33: Drivers of buyer power in the generics market in Germany, 2020
Figure 34: Drivers of supplier power in the generics market in Germany, 2020
Figure 35: Factors influencing the likelihood of new entrants in the generics market in Germany, 2020
Figure 36: Factors influencing the threat of substitutes in the generics market in Germany, 2020
Figure 37: Drivers of degree of rivalry in the generics market in Germany, 2020
Figure 38: Italy generics market value: $ million, 2016-20
Figure 39: Italy generics market volume: %, 2016-20
Figure 40: Italy generics market geography segmentation: % share, by value, 2020
Figure 41: Italy generics market value forecast: $ million, 2020-25
Figure 42: Italy generics market volume forecast: %, 2020-25
Figure 43: Forces driving competition in the generics market in Italy, 2020
Figure 44: Drivers of buyer power in the generics market in Italy, 2020
Figure 45: Drivers of supplier power in the generics market in Italy, 2020
Figure 46: Factors influencing the likelihood of new entrants in the generics market in Italy, 2020
Figure 47: Factors influencing the threat of substitutes in the generics market in Italy, 2020
Figure 48: Drivers of degree of rivalry in the generics market in Italy, 2020
Figure 49: Japan generics market value: $ billion, 2016-20
Figure 50: Japan generics market volume: %, 2016-20
Figure 51: Japan generics market geography segmentation: % share, by value, 2020
Figure 52: Japan generics market value forecast: $ billion, 2020-25
Figure 53: Japan generics market volume forecast: %, 2020-25
Figure 54: Forces driving competition in the generics market in Japan, 2020
Figure 55: Drivers of buyer power in the generics market in Japan, 2020
Figure 56: Drivers of supplier power in the generics market in Japan, 2020
Figure 57: Factors influencing the likelihood of new entrants in the generics market in Japan, 2020
Figure 58: Factors influencing the threat of substitutes in the generics market in Japan, 2020
Figure 59: Drivers of degree of rivalry in the generics market in Japan, 2020
Figure 60: Russia generics market value: $ billion, 2016-20
Figure 61: Russia generics market volume: %, 2016-20
Figure 62: Russia generics market geography segmentation: % share, by value, 2020
Figure 63: Russia generics market value forecast: $ billion, 2020-25
Figure 64: Russia generics market volume forecast: %, 2020-25
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Teva Pharmaceutical Industries Limited
- Apotex, Inc.
- Les Laboratoires Servier
- STADA Arzneimittel AG
- Daiichi Sankyo Co Ltd
- Sawai Pharmaceutical Co Ltd
- Viatris Inc.
- Krka, d. d., Novo mesto
- Sanofi SA
- Abbott Laboratories
- Pfizer Inc.
